Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage

Last updated: May 1, 2016
Sponsor: RenJi Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Urologic Cancer

Urothelial Cancer

Urothelial Tract Cancer

Treatment

N/A

Clinical Study ID

NCT02734329
RenJiH-2016006
  • Ages 15-80
  • All Genders

Study Summary

Zero ischemia laparoscopic radio frequency ablation assisted tumor enucleation has been proved to enable tumor excision with relatively better renal function preservation comparing with conventional laparoscopic partial nephrectomy for T1a renal cell carcinoma (RCC) in a randomized clinical trial in single center. The investigators want to explore this technique to T1 RCC patients in randomized clinical trial in multiple centers.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients with sporadic, unilateral, newly diagnosed T1 presumed renal cell carcinoma

  • patients scheduled for laparoscopic nephron sparing surgery

  • patients agreeable to participate in this long-term follow-up study

Exclusion

Exclusion Criteria:

  • patients' aged >80 years

  • patients with other renal diseases,(including kidney stone, glomerular nephritis,etc.) which might affect the renal function of the operative kidney

  • patients not able to tolerate the laparoscopic procedure

  • patients with previous renal surgery or history of any inflammatory conditions of theoperative kidney

  • patients with the renal tumor involving urinary collecting system

Study Design

Total Participants: 600
Study Start date:
April 01, 2016
Estimated Completion Date:

Connect with a study center

  • Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

    Shanghai, 200127
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.